RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 120 filers reported holding RA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 4.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $32,000 | +146.2% | 266 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | +8.3% | 266 | 0.0% | 0.00% | – |
| Q4 2019 | $12,000 | +71.4% | 266 | -11.3% | 0.00% | – |
| Q3 2019 | $7,000 | -12.5% | 300 | +12.4% | 0.00% | – |
| Q2 2019 | $8,000 | +33.3% | 267 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | +200.0% | 267 | +113.6% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | +100.0% | 125 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | – | 125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,851,808 | $20,453,000 | 1.57% |
| NEA Management Company, LLC | 5,493,636 | $29,171,000 | 1.30% |
| Foresite Capital Management IV, LLC | 450,000 | $2,390,000 | 0.99% |
| Novo Holdings A/S | 1,465,838 | $7,784,000 | 0.98% |
| Consonance Capital Management LP | 1,454,761 | $7,725,000 | 0.71% |
| VHCP Management II, LLC | 544,612 | $2,892,000 | 0.70% |
| ACUTA CAPITAL PARTNERS, LLC | 270,000 | $1,434,000 | 0.23% |
| Athanor Capital, LP | 67,150 | $357,000 | 0.16% |
| Rock Springs Capital Management LP | 600,000 | $3,186,000 | 0.14% |
| Eventide Asset Management | 388,000 | $2,060,000 | 0.10% |